If you are in crisis, help is available now. Call or text 988 to reach the Suicide & Crisis Lifeline, or text HOME to 741741. If someone is in immediate danger, call 911. This site is information only and cannot provide urgent help.

ketamineflorida.org
Menu

Is Ketamine Therapy Legal in Florida?

Yes. Ketamine is a federal Schedule III controlled substance, and physicians licensed in Florida may prescribe and administer it — including off-label for depression, which means for a purpose the FDA has not formally approved.

The federal baseline

Ketamine and its mirror-image form esketamine are Schedule III controlled substances under federal law, which means they have accepted medical uses but can be misused. as of 18 Jul 2026 · U.S. Drug Enforcement Administration (source 2, opens in a new tab)Esketamine has no separate DEA listing; it is covered as an enantiomer of ketamine, and the Spravato label carries the CIII designation.

Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 2, opens in a new tab)

The FDA approved Spravato (esketamine) nasal spray on 5 March 2019, for use with an oral antidepressant, for adults with treatment-resistant depression. as of 5 Mar 2019 · U.S. Food and Drug Administration (source 4, opens in a new tab)

Spravato is available only through a restricted safety programme called a Risk Evaluation and Mitigation Strategy (REMS), and may only be given in a certified healthcare setting under a provider's direct observation. Patients never take it home. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 5, opens in a new tab)

Florida law: who may give it

Florida medical doctors and osteopathic physicians may administer ketamine within their scope of practice. Florida's autonomous registration for advanced practice registered nurses does allow controlled-substance prescribing, but it limits autonomous practice to primary care — family medicine, general paediatrics and general internal medicine — so it does not cover a psychiatric or anaesthesia ketamine practice. A certified registered nurse anaesthetist works under an approved protocol with physician supervision. Physician assistants are never autonomous in Florida. as of 18 Jul 2026 · Florida Legislature (source 2, opens in a new tab)Florida law requires the physician assistant prohibited-drug list to include general anaesthetics, and ketamine is labelled as one. Whether that reaches the low doses used for depression is unsettled, and no Florida board has ruled on it.

Who may own a clinic in Florida

Florida does not have a general prohibition on corporate ownership of medical practices. What it regulates instead is clinic licensing: operating a clinic in Florida requires a licence from the Agency for Health Care Administration, with each location licensed separately. Practices wholly owned by physicians — or by advanced practice registered nurses — are exempt from that licensing requirement. as of 18 Jul 2026 · The Florida Senate (source 1, opens in a new tab)Florida separately treats fee-splitting and patient brokering as serious offences, so the absence of a corporate-practice ban does not mean referral arrangements are unregulated.

This matters to you only indirectly, but it shapes which clinics exist here and how they are structured.

Electronic-Florida Online Reporting of Controlled Substance Evaluation (E-FORCSE)

Prescription monitoring is where published information about ketamine most often goes wrong, because three different questions get collapsed into one. They have different answers.

What must be reported

Florida's monitoring system is E-FORCSE, run by the Department of Health. Dispensers must report each Schedule II to V controlled substance dispensed, no later than the close of the next business day. The law expressly excludes all acts of administration from reporting, along with dispensing inside the corrections system and dispensing to anyone under 16. as of 18 Jul 2026 · Florida Department of Health (source 2, opens in a new tab)

When a prescriber must check

Before prescribing or dispensing any controlled substance to a patient aged 16 or over, a Florida prescriber or dispenser must consult E-FORCSE to review that patient's dispensing history. This covers every controlled substance, not just opioids. The only exceptions are non-opioid Schedule V medicines and patients admitted to hospice. as of 18 Jul 2026 · The Florida Senate (source 2, opens in a new tab)If the system is unavailable, the prescriber must record why and may not prescribe more than a three-day supply. That three-day figure is a ceiling during an outage, not a general exemption.

Does this apply to ketamine?

Partly, and it depends on how you receive it. Ketamine is Schedule III in Florida, so a prescription written for you does trigger the database check. But an infusion given to you inside a clinic is an act of administration, which Florida expressly excludes from the database — so nothing about that dose is recorded, and there is nothing to check. Compounded ketamine sent to your home from a pharmacy is squarely covered. as of 18 Jul 2026 · Florida Legislature (source 2, opens in a new tab)Spravato is the harder case: it is genuinely prescribed even though you take it at the clinic. No Florida guidance addresses medicines dispensed by a pharmacy to a clinic, so we do not state a settled answer.

Telehealth

Florida's telehealth restriction on prescribing controlled substances applies to Schedule II medicines only. Ketamine and esketamine are Schedule III, so that restriction does not apply to them, and Florida law does not otherwise require an in-person examination first. as of 18 Jul 2026 · The Florida Senate (source 6, opens in a new tab)Federal DEA telemedicine flexibilities run separately and expire at the end of 2026, and they require video rather than a phone call. Spravato cannot be prescribed for home use in any case, because it must be given in a certified setting.

Through 31 December 2026, clinicians registered with the DEA may prescribe controlled medicines such as ketamine after a video telemedicine visit, without an in-person examination first. as of 1 Jan 2026 · Drug Enforcement Administration (source 1, opens in a new tab)This is the fourth temporary extension. Each of the previous three was issued close to its expiry date, so the position may change late in 2026.

The DEA's proposed rule to create a special registration for prescribing controlled medicines by telemedicine, published on 17 January 2025, is still only a proposal and has not been finalised. as of 17 Jan 2025 · Drug Enforcement Administration (source 1, opens in a new tab)No final rule and no withdrawal notice has been published. A rule can also be shelved without a formal withdrawal, so this should not be read as a statement that the DEA intends to finalise it.

Two things are worth holding onto here. The federal flexibility has a hard end date and has been extended four times at short notice, so anything you read about telehealth ketamine access needs a date attached to it. And a stricter state rule still applies regardless of what federal law permits.

Spravato is a separate case entirely: it must be taken in a certified clinic under observation, so it cannot be prescribed for home use whatever the telehealth position is.

How to check a clinician before you book

  1. Go to the Florida Board of Medicine licence lookup.
  2. Search by name, and confirm the licence is current and unrestricted.
  3. Look for disciplinary history. It is published for a reason, and it is the single most useful thing you can check in five minutes.
  4. If you are seeking Spravato specifically, confirm the clinic is REMS-certified using the official locator . No other directory, including ours, can tell you that.